DIOVAN 80 MG FILM-COATED TABLETS

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
09-11-2020
제품 특성 요약 제품 특성 요약 (SPC)
11-10-2020
공공 평가 보고서 공공 평가 보고서 (PAR)
17-08-2016

유효 성분:

VALSARTAN

제공처:

NOVARTIS ISRAEL LTD

ATC 코드:

C09CA03

약제 형태:

FILM COATED TABLETS

구성:

VALSARTAN 80 MG

관리 경로:

PER OS

처방전 유형:

Required

Manufactured by:

SIEGFRIED BARBERA, S.L., SPAIN

치료 그룹:

VALSARTAN

치료 영역:

VALSARTAN

치료 징후:

For treatment of hypertension. Diovan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Diovan signicantly reduced hospitalisations for heart failure. There is no evidence that Diovan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

승인 날짜:

2023-03-31

환자 정보 전단

                                ؟ءاودلا لامعتسإ ةيفيك )3
.بيبطلا تاميلعت بسح رضحتسملا لامعتسإ
ً
امئاد بجي
صوصخب
ً
اقثاو نكت مل اذإ يلديصلا نم وأ بيبطلا
نم حاضيتسلإا كيلع
.رضحتسملاب جلاعلا ةقيرطو ةيئاودلا
ةعرجلا
ةيئاودلا ةعرجلا .طقف بيبطلا لبق نم
ناددحي جلاعلا ةقيرطو ةيئاودلا ةعرجلا
.ءاودلا فص
ُ
و هلجأ نم بابطتسلإاب ةقلعتم
ةيدايتعلإا
.قوف امو ةنس 65 رامعأب ىضرم ىدل ناڤويد
لامعتسإ ناكملإاب
.ةنس 18 رمع نود نيقهارملاو لافطلأا
،عضرلل صصخم ريغ ءاودلا اذه
.اهب ىصوملا ةيئاودلا ةعرجلا زواجت زوجي
لا
مهنم ريثكلا .ةلكشملا تاملاعب عفترملا
مدلا طغض ىضرم ظحلاي لا ةداع
ىتح كبيبط ىدل تارايزلا ىلع ةبظاوملا
مهملا نم اذل .ديج لكشب نورعشي
.ديج لكشب ترعش ولو
:لوانتلا ةقيرط
قحس صوصخب تامولعم رفوتت لا .ماعط نودب
وأ عم ناڤويد لوانت ناكملإاب
لوانت بجي .ءاملا نم سأك عم ناڤويد علب
بجي .يلطملا صرقلا غضم وأ
دنبلا نعمتب أرقإ ءاجرلا رطشلا
تاميلعتل .موي لك نم تقولا سفن يف ناڤويد
."ةبلعلا ىوتحم وه امو ءاودلا ودبي فيك"
ربكأ ةيئاود ةعرج أطخلاب تلوانت اذإ
ةيعضول لقتنإو كبيبط ىلإ
ً
لااح هجوت ءامغإ وأ/و ديدش راودب رعشت
تنك اذإ
،ءاودلا نم أطخلاب لفط علب اذإ وأ ةطرفم
ةيئاود ةعرج تلوانت اذإ .ءاقلتسلإا
.ءاودلا ةبلع كعم رضحأو ىفشتسملا يف
ئراوطلا ةفرغل وأ بيبطلا ىلإ
ً
لااح هجوت
ناڤويد لوانت تيسن 
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                1
DIO API SEP23 V1.3
1. NAME OF THE MDICINAL PRODUCT
DIOVAN
®
40 mg film-coated tablets
DIOVAN
®
80 mg film-coated tablets
DIOVAN
®
160 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 40 mg of valsartan.
Each film-coated tablet contains 80 mg of valsartan.
Each film-coated tablet contains 160 mg of valsartan.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Diovan
®
40 mg Film-coated tablet: Yellow, ovaloid film-coated tablet with
bevelled
edges, slightly covex, scored on one side; with debossing “D” on
one side of the
score and “O” on the other side of the score and “NVR” on the
reverse side of the
tablet. The tablet can be divided into equal doses.
Diovan
®
80 mg Film-coated tablet: Pale red, round film-coated tablet with
bevelled
edges, scored on one side with debossing “D” on one side of the
score and “V” on
the other side of the score and “NVR” on the reverse side of the
tablet.
The score line is only to facilitate breaking for ease of swallowing
and not to divide
into equal doses.
Diovan
®
160 mg Film-coated tablet: Grey-orange, ovaloid film-coated tablet
slightly
convex, scored on one side with debossing “DX” on one side of the
score "DX" on the
other side of the score and “NVR” on the reverse side of the
tablet.
The score line is only to facilitate breaking for ease of swallowing
and not to divide
into equal doses.
There is no information regarding chewing or crushing of the tablets.
4
.
CLINICAL PARTICULARS
Page 2 of 21
DIO SPI SEP23 V1.3
4.1
Therapeutic indications
Hypertension (Diovan 80 mg and 160 mg)
For treatment of hypertension.
Heart failure (Diovan 40 mg, 80 mg and 160 mg)
Diovan is indicated for the treatment of heart failure (NYHA class
II-IV) in patients
who are intolerant of angiotensin converting enzyme inhibitors. In a
controlled clinical
trial, Diovan significantly reduced hospitalizations for heart
failure. There is no
evidence that Diovan provides added benefits when it is us
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 아랍어 09-11-2020
환자 정보 전단 환자 정보 전단 히브리어 27-09-2023

이 제품과 관련된 검색 알림